← Back to Search

MAPS App for Suicidal Thoughts

N/A
Waitlist Available
Research Sponsored by Butler Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Presence of suicidal ideation and/or suicidal behavior in the past month
Between the ages of 18 and 70
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights

Study Summary

This trial is testing a new suicide prevention app called MAPS. The app is designed to be personalized and to help people who are struggling with suicidal thoughts. The trial will test the feasibility, acceptability, and safety of the app, and establish key parameters for its effectiveness.

Who is the study for?
This trial is for adults aged 18-70 who have experienced suicidal thoughts or behaviors in the past month. Participants must own a smartphone and be able to read, write, and understand English to complete study tasks. It's not suitable for individuals with severe psychotic or manic symptoms.Check my eligibility
What is being tested?
The trial is testing a new personalized smartphone app called MAPS designed to prevent suicide. The study will assess how practical and acceptable this technology is, its safety, and its potential impact on reducing suicidal thoughts, behaviors, and re-hospitalization.See study design
What are the potential side effects?
Since this intervention involves using a mobile application rather than medication or medical procedures, traditional side effects are not expected. However, there may be psychological impacts from engaging with content about suicide prevention which will be closely monitored.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have had thoughts or actions of suicide in the last month.
Select...
I am between 18 and 70 years old.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Acceptability of MAPS Intervention
Acceptability of Research (Dropout)
Acceptability of Research (Recruitment)
+7 more
Secondary outcome measures
Reduction of Negative Affect (target mechanism)
Self-Efficacy (target mechanism)
Use of MAPS Intervention-delivered Coping Strategies (target mechanism)

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Mobile Application to Prevent Suicide (MAPS)Experimental Treatment1 Intervention
Participants receiving MAPS will receive the Safety Planning Intervention (SPI) which will be uploaded into the smartphone app. They will be prompted four times per day to complete a brief ecological momentary assessment "check-in" inquiring about their cognitions, affect, and behavior, including suicidal thoughts and behaviors. Based on these responses, they will be provided with coping strategies from their safety plans and from a database of coping strategies created by study staff. They will also have access to emergency phone numbers, the coping strategies database, and can communicate with their study clinician through a text-like interface in the app. They will receive this intervention for one month.
Group II: EMA Monitoring Only (EMO)Active Control1 Intervention
Participants in this condition will receive the Safety Planning Intervention (SPI) and will receive ecological momentary assessment prompts on the same schedule as the MAPS condition. However, they will not have access to any other MAPS features.

Find a Location

Who is running the clinical trial?

Butler HospitalLead Sponsor
129 Previous Clinical Trials
16,368 Total Patients Enrolled
11 Trials studying Suicide
611 Patients Enrolled for Suicide
National Institute of Mental Health (NIMH)NIH
2,774 Previous Clinical Trials
2,674,253 Total Patients Enrolled
111 Trials studying Suicide
1,156,701 Patients Enrolled for Suicide
Brown UniversityOTHER
452 Previous Clinical Trials
562,146 Total Patients Enrolled
12 Trials studying Suicide
3,924 Patients Enrolled for Suicide

Media Library

EMA Monitoring Only Clinical Trial Eligibility Overview. Trial Name: NCT05202756 — N/A
Suicide Research Study Groups: EMA Monitoring Only (EMO), Mobile Application to Prevent Suicide (MAPS)
Suicide Clinical Trial 2023: EMA Monitoring Only Highlights & Side Effects. Trial Name: NCT05202756 — N/A
EMA Monitoring Only 2023 Treatment Timeline for Medical Study. Trial Name: NCT05202756 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is my profile compatible with the requirements for this medical research project?

"Candidates are eligible for this research if they have a history of suicidal ideation and are aged between 18-70. This trial is hoping to recruit approximately 50 individuals in total."

Answered by AI

Does this trial admit geriatric patients?

"This research study only accepts subjects aged between 18 and 70. Those younger than 18 can partake in 83 different trials, while those over 65 may join 152 different studies."

Answered by AI

Do you still have openings for participants in this trial?

"Clinicaltrials.gov reports that, at present, this trial is not accepting new patients. The initial posting was made on October 1st 2022 and the latest update to the listing occurred on August 19th of the same year. Although recruitment for this specific study has been suspended, there are 240 other trials actively searching for applicants presently."

Answered by AI

Who else is applying?

What state do they live in?
Arizona
How old are they?
18 - 65
What site did they apply to?
Butler Hospital
Brown University
What portion of applicants met pre-screening criteria?
Met criteria
~33 spots leftby May 2025